Equities research analysts expect that National Health Investors Inc (NYSE:NHI) will report earnings of $1.34 per share for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for National Health Investors’ earnings, with the lowest EPS estimate coming in at $1.32 and the highest estimate coming in at $1.35. National Health Investors reported earnings of $1.25 per share during the same quarter last year, which would indicate a positive year over year growth rate of 7.2%. The business is expected to report its next quarterly earnings results on Tuesday, May 8th.
On average, analysts expect that National Health Investors will report full year earnings of $5.49 per share for the current fiscal year, with EPS estimates ranging from $5.45 to $5.52. For the next year, analysts anticipate that the business will report earnings of $5.65 per share, with EPS estimates ranging from $5.63 to $5.70. Zacks Investment Research’s EPS averages are an average based on a survey of research analysts that cover National Health Investors.
National Health Investors (NYSE:NHI) last announced its earnings results on Friday, February 16th. The real estate investment trust reported $0.90 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.33 by ($0.43). National Health Investors had a net margin of 57.19% and a return on equity of 12.20%. The firm had revenue of $71.06 million during the quarter, compared to analyst estimates of $71.36 million.
A number of equities research analysts recently issued reports on the company. Stephens set a $79.00 target price on National Health Investors and gave the company a “buy” rating in a research report on Friday, January 12th. Cantor Fitzgerald reissued a “hold” rating and issued a $85.00 target price on shares of National Health Investors in a research report on Wednesday, January 17th. SunTrust Banks set a $75.00 target price on National Health Investors and gave the company a “hold” rating in a research report on Monday, January 22nd. KeyCorp reissued a “hold” rating on shares of National Health Investors in a research report on Friday, November 24th. Finally, Hilliard Lyons raised National Health Investors from a “neutral” rating to a “buy” rating in a research report on Friday, February 16th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $77.75.
Shares of National Health Investors (NHI) traded down $0.19 during trading on Monday, reaching $68.30. The company had a trading volume of 5,325 shares, compared to its average volume of 273,232. National Health Investors has a 1-year low of $62.71 and a 1-year high of $81.60. The firm has a market cap of $2,840.00, a price-to-earnings ratio of 17.65, a PEG ratio of 3.52 and a beta of 0.48. The company has a debt-to-equity ratio of 0.87, a quick ratio of 13.85 and a current ratio of 13.85.
The business also recently declared a quarterly dividend, which will be paid on Thursday, May 10th. Shareholders of record on Friday, March 30th will be paid a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a yield of 5.86%. This is an increase from National Health Investors’s previous quarterly dividend of $0.95. The ex-dividend date is Wednesday, March 28th. National Health Investors’s dividend payout ratio (DPR) is currently 97.94%.
In related news, CEO D. Eric Mendelsohn purchased 2,000 shares of the firm’s stock in a transaction on Thursday, February 22nd. The stock was purchased at an average cost of $65.47 per share, for a total transaction of $130,940.00. Following the completion of the purchase, the chief executive officer now directly owns 10,580 shares in the company, valued at $692,672.60. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP John L. Spaid purchased 500 shares of the firm’s stock in a transaction on Thursday, February 22nd. The stock was bought at an average price of $64.95 per share, with a total value of $32,475.00. Following the completion of the purchase, the vice president now owns 971 shares of the company’s stock, valued at $63,066.45. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 2,812 shares of company stock valued at $183,910. Corporate insiders own 5.19% of the company’s stock.
A number of hedge funds have recently bought and sold shares of NHI. First Trust Advisors LP grew its stake in National Health Investors by 29.8% in the third quarter. First Trust Advisors LP now owns 99,856 shares of the real estate investment trust’s stock valued at $7,718,000 after purchasing an additional 22,938 shares in the last quarter. Aperio Group LLC grew its stake in National Health Investors by 14.7% in the third quarter. Aperio Group LLC now owns 15,403 shares of the real estate investment trust’s stock valued at $1,190,000 after purchasing an additional 1,971 shares in the last quarter. Chicago Equity Partners LLC bought a new position in National Health Investors in the third quarter valued at approximately $606,000. Stevens Capital Management LP bought a new position in National Health Investors in the third quarter valued at approximately $311,000. Finally, Swiss National Bank grew its stake in National Health Investors by 2.5% in the third quarter. Swiss National Bank now owns 68,520 shares of the real estate investment trust’s stock valued at $5,296,000 after purchasing an additional 1,700 shares in the last quarter. Hedge funds and other institutional investors own 71.89% of the company’s stock.
TRADEMARK VIOLATION WARNING: “National Health Investors Inc (NHI) Expected to Announce Earnings of $1.34 Per Share” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this piece of content can be read at https://ledgergazette.com/2018/03/15/national-health-investors-inc-nhi-expected-to-announce-earnings-of-1-34-per-share.html.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.